Since 1976
Ramco Laboratories, Inc.
Ramco Laboratories, Inc., formed in 1976, manufactures, assembles, and markets proprietary medical diagnostic test kits.
Ramco sells to physician groups, hospitals, and reference laboratories in the U.S. and to distributors and directly to customers in international markets.
Ramco is a privately held company founded by Dr. Clarence Alfrey an MD, PhD. Dr. Alfrey is a leading hematologist in the Texas Medical Center, a researcher for NASA, on staff at the Baylor College of Medicine, the retired medical director of the Gulf Coast Regional Blood Center, and a former President of the Harris County Medical Society.
One of the highlights of the exclusive Ramco portfolio is the "Cand Tec" test, for which Ramco is the exclusive producer worldwide. The "Cand Tec" test is a latex agglutination test for detecting antigen associated with systemic Candidiasis. Other highlights are the 30 years expertise for Ferritin determinations (EIA and RIA) or the EIA microplate assay for quantifying serum transferrin receptor ("Transferrin Receptor").
BÜHLMANN represents Ramco Laboratories in Switzerland and in Austria.
List of actually requested Ramco Products in Switzerland and Austria.more
Visit Ramco Laboratories, Inc. Homepage.
Contact
Baselstr. 55
CH-4124 Schönenbuch
Switzerland
Fon: +41 61 487 12 12
Fax: +41 61 487 12 34
info@buhlmannlabs.ch
Your local distributor
Order
About us
Job opportunities
Search
News
BUHLMANN as gold sponsor of the 5th Santorini Pharmacogenetics Conference
Functional Genomics Towards Personalized Health Care The 5th Santorini Conference will take place in Thira, Greece, on September 30th , October 1st and 2 more
Measuring of Mineralwaters and Softdrinks on Arena and Aquakem
The high expectations in speed, accuracy and precision have been achieved in an evaluation study on Arena 30 at Feldschlösschen (Carlsberg Group), Rheinfe more
BÜHLMANN Calprotectin Test introduced in Belgium
The Hartziekenhuis Hospital in Belgium introduced the BÜHLMANN Calprotectin Assay for testing of faecal samples of IBD patients. A thorough evaluation pro more
Distribution of BioPorto’s NGAL ELISA
In January 2010 BÜHLMANN starts the distribution of the innovative diagnostic products of BioPorto in Switzerland , Austria and France . more
BÜHLMANN Core | BÜHLMANN Molecular | BÜHLMANN Medical | BÜHLMANN Industrial | Customer Relations | About Us |
Contact |
